Litigation Details for AstraZeneca LP v. Mylan Inc. (N.D.W. Va. 2015)
✉ Email this page to a colleague
AstraZeneca LP v. Mylan Inc. (N.D.W. Va. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-11-02 |
| Court | District Court, N.D. West Virginia | Date Terminated | 2017-07-19 |
| Cause | 35:145 Patent Infringement | Assigned To | Irene Patricia Murphy Keeley |
| Jury Demand | None | Referred To | |
| Patents | 6,251,910; 6,525,060; 7,250,419; 7,265,124; 8,425,934 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in AstraZeneca LP v. Mylan Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for AstraZeneca LP v. Mylan Inc. (N.D.W. Va. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-11-01 | 1 | prior to expiration of AstraZeneca’s U.S. Patent Nos. 6,251,910 (“the ’910 T.. NOV -2 2015 WVN D Case…Exhibit A - US Patent Information, # 2 Exhibit B - US Patent Information, # 3 Exhibit C - US Patent Information… 14 Page|D #: 2 patent”), 6,525,060 (“the ’060 patent”), 7,250,419 (“the ’419 patent”), 7,265,124 (“the…Information, # 4 Exhibit D - US Patent Information, # 5 Exhibit E - US Patent Information, # 6 Civil Cover Sheet…ACTION l. This is an action for patent infringement arising under the patent laws of the United States, Title | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
